Research & Development
Eurofins Viracor introduces BKV inSIGHT T-cell immunity panel for BK virus immune monitoring in kidney transplant patients
23 July 2026 - Diagnostic specialist Eurofins Viracor, a subsidiary of product testing provider Eurofins Scientific (Euronext Paris:ERF), announced on Wednesday the commercial availability of the BKV ...
GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC
23 July 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib), a ROS1 selective inhib...
Hugel Aesthetics expands US presence
22 July 2026 - Australian pharmaceutical company Hugel Aesthetics announced on Tuesday a major expansion of its US business as part of its long-term growth strategy.The expansion includes the launch o...
European Commission expands Crysvita approval to infants with XLH
21 July 2026 - Kyowa Kirin EMEA, a subsidiary of Japanese pharmaceutical company Kyowa Kirin Co Ltd (TSE:4151), said on Tuesday that the European Commission has approved an expanded indication for Cry...
AbelZeta's C-CAR168 receives EMA PRIME designation for Lupus Nephritis and Systemic Lupus Erythematosus
21 July 2026 - Clinical-stage biopharmaceutical company AbelZeta Pharma Inc announced on Monday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) ha...
Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date
17 July 2026 - Swedish biopharmaceutical company Camurus AB (STO:CAMX) said on Friday that the US Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application for CA...
Related Headlines

World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601

Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial

MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA

FDA grants priority review to Genentech's Gazyva for primary membranous nephropathy

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil

European Commission approves Erbitux combination for first-line BRAF V600E-mutant mCRC

US FDA accepts BioMarin's sNDA for full approval of VOXZOGO (vosoritide) for children with achondroplasia

Eisai reports new data showing etalanetug reduces Alzheimer's Disease tau tangle‑specific biomarker

FDA approves Sanofi's subcutaneous Sarclisa Escena as first anticancer therapy delivered via on-body injector

Accord BioPharma's second pegfilgrastim biosimilar to NEULASTA approved by US FDA

BiBBInstruments signs first European distribution deal for EndoDrill GI with Palex Spain

Vector Science and Therapeutics names Darryl Drake Jr. president of Valor athlete and performance division

Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection

Vanda Pharmaceuticals' investigational therapy for Charcot-Marie-Tooth disease type 2S granted FDA Rare Pediatric Disease Designation